313 related articles for article (PubMed ID: 32255561)
21. Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses.
Mergaert AM; Denny MF; Kingstad-Bakke B; Bawadekar M; Bashar SJ; Warner TF; Suresh M; Shelef MA
J Immunol Res; 2022; 2022():5258221. PubMed ID: 35083342
[TBL] [Abstract][Full Text] [Related]
22. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation.
Andrade F; Darrah E; Gucek M; Cole RN; Rosen A; Zhu X
Arthritis Rheum; 2010 Jun; 62(6):1630-40. PubMed ID: 20201080
[TBL] [Abstract][Full Text] [Related]
23. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases.
Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA
J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117
[TBL] [Abstract][Full Text] [Related]
24. Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis.
Martin M; Nilsson SC; Eikrem D; Fromell K; Scavenius C; Vogt LM; Bielecka E; Potempa J; Enghild JJ; Nilsson B; Ekdahl KN; Kapetanovic MC; Blom AM
Front Immunol; 2023; 14():1203506. PubMed ID: 37426666
[TBL] [Abstract][Full Text] [Related]
25. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
[TBL] [Abstract][Full Text] [Related]
26. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
[TBL] [Abstract][Full Text] [Related]
27. Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4.
Yoshida K; Ito H; Kurosaka D; Ikeda R; Noda K; Saito M; Kurosaka D
Sci Rep; 2023 May; 13(1):7528. PubMed ID: 37160933
[TBL] [Abstract][Full Text] [Related]
28. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
30. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
Front Immunol; 2018; 9():2696. PubMed ID: 30515171
[No Abstract] [Full Text] [Related]
32. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen.
Auger I; Martin M; Balandraud N; Roudier J
Arthritis Rheum; 2010 Jan; 62(1):126-31. PubMed ID: 20039406
[TBL] [Abstract][Full Text] [Related]
33. Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis.
El Shikh MEM; El Sayed R; Nerviani A; Goldmann K; John CR; Hands R; Fossati-Jimack L; Lewis MJ; Pitzalis C
J Autoimmun; 2019 Dec; 105():102297. PubMed ID: 31277965
[TBL] [Abstract][Full Text] [Related]
34. Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis.
de França NR; Ménard HA; Lora M; Zhou Z; Rauch J; Hitchon C; Andrade LEC; Colmegna I
Arthritis Res Ther; 2022 Jan; 24(1):23. PubMed ID: 35027076
[TBL] [Abstract][Full Text] [Related]
35. Association of Baseline Peptidylarginine Deiminase 4 Autoantibodies With Favorable Response to Treatment Escalation in Rheumatoid Arthritis.
Darrah E; Yu F; Cappelli LC; Rosen A; O'Dell JR; Mikuls TR
Arthritis Rheumatol; 2019 May; 71(5):696-702. PubMed ID: 30507066
[TBL] [Abstract][Full Text] [Related]
36. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
Vitkov L; Hannig M; Minnich B; Herrmann M
Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
[TBL] [Abstract][Full Text] [Related]
37. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
Damgaard D; Senolt L; Nielsen CH
Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations.
Ferucci ED; Darrah E; Smolik I; Choromanski TL; Robinson DB; Newkirk MM; Fritzler MJ; Rosen A; El-Gabalawy HS
J Rheumatol; 2013 Sep; 40(9):1523-8. PubMed ID: 23908443
[TBL] [Abstract][Full Text] [Related]
39. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
[TBL] [Abstract][Full Text] [Related]
40. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
